<?xml version="1.0" encoding="UTF-8"?>

<EvidenceVariable xmlns="http://hl7.org/fhir">
  <id value="583773"/>
  <meta>
    <versionId value="2"/>
    <lastUpdated value="2026-07-27T13:49:52.712Z"/>
    <profile value="http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: EvidenceVariable 583773</b></p><a name="583773"> </a><a name="hc583773"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 2; Last updated: 2026-07-27 13:49:52+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-variable-definition.html">VariableDefinition</a></p></div><p><b>ArtifactPublicationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}">Active</span></p><p><b>url</b>: <a href="https://fevir.net/resources/EvidenceVariable/583773">https://fevir.net/resources/EvidenceVariable/583773</a></p><p><b>identifier</b>: FEvIR Object Identifier/583773, FEvIR Linking Identifier/NCT05327010-secondaryOutcome-2</p><p><b>name</b>: Progression_free_survival_NCT05327010</p><p><b>title</b>: Progression-free survival (NCT05327010)</p><p><b>citeAs</b>: </p><div><p>Progression-free survival (NCT05327010) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 583773. Revised 2026-07-27. Available at: https://fevir.net/resources/EvidenceVariable/583773. Computable resource at: https://fevir.net/resources/EvidenceVariable/583773#json.</p>
</div><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Assessed by radiographic disease assessments per RECIST v1.1.</p>
</div><p><b>copyright</b>: </p><div><p>Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).</p>
</div><h3>Definitions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:">Progression-free survival Assessed by radiographic disease assessments per RECIST v1.1.</span></td></tr></table><p><b>handling</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 evidence-variable-handling-not-specified}">Evidence variable handling not specified</span></p><h3>Timings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td>From start of treatment to time of progression or death, whichever occurs first, assessed up to 2 years</td></tr></table></div>
  </text>
  <extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
    <valueCodeableConcept>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
        <code value="active"/>
        <display value="Active"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <url value="https://fevir.net/resources/EvidenceVariable/583773"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net/FOI"/>
    <value value="583773"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <identifier>
    <type>
      <text value="FEvIR Linking Identifier"/>
    </type>
    <system value="https://fevir.net/FLI"/>
    <value value="NCT05327010-secondaryOutcome-2"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <name value="Progression_free_survival_NCT05327010"/>
  <title value="Progression-free survival (NCT05327010)"/>
  <citeAs value="Progression-free survival (NCT05327010) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 583773. Revised 2026-07-27. Available at: https://fevir.net/resources/EvidenceVariable/583773. Computable resource at: https://fevir.net/resources/EvidenceVariable/583773#json."/>
  <status value="active"/>
  <author>
    <name value="Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"/>
  </author>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description value="Assessed by radiographic disease assessments per RECIST v1.1."/>
  <copyright value="Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."/>
  <definition>
    <concept>
      <text value="Progression-free survival Assessed by radiographic disease assessments per RECIST v1.1."/>
    </concept>
  </definition>
  <handling>
    <coding>
      <system value="https://fevir.net/resources/CodeSystem/179423"/>
      <code value="evidence-variable-handling-not-specified"/>
      <display value="Evidence variable handling not specified"/>
    </coding>
  </handling>
  <timing>
    <text value="From start of treatment to time of progression or death, whichever occurs first, assessed up to 2 years"/>
  </timing>
</EvidenceVariable>